Taiwan Biomaterial Co., Ltd.
6649
Rank in Stocks
#23081
Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan,... Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan, focuses on the innovation, development, and commercialization of medical devices throughout Taiwan. Their product offerings include Foamagen, a pioneering dural substitute characterized by its foamy structure. The company also provides a sophisticated negative pressure catheter system engineered for stroke intervention, which efficiently suctions and removes cerebrovascular embolism blood clots, accompanied by a specialized nickel-titanium guidewire essential for guiding intricate neurovascular procedures. Additionally, Taiwan Biomaterial develops advanced tissue repair and regeneration solutions specifically targeting the treatment of early-stage osteoarthritis.
Share Price
$1.09
Last synced: 2026-11-09
Market Cap
$45.96M
Change (1 day)
5.08%
Change (1 year)
-32.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiwan Biomaterial Co., Ltd. (6649)
Category
Healthcare
EPS for Taiwan Biomaterial Co., Ltd. (6649)
EPS as of June 2026 TTM: $0.02
According to Taiwan Biomaterial Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $0.04, an increase over its 2024 EPS of 0.00.
EPS history for Taiwan Biomaterial Co., Ltd. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.02 | -39.75% |
| 2025 | $0.04 | -3,530.77% |
| 2024 | 0.00 | -83.33% |
| 2023 | $-0.01 | -128.78% |
| 2022 | $0.03 | -152.12% |
| 2021 | $-0.05 | -9.88% |
| 2020 | $-0.06 | -20.41% |
| 2019 | $-0.07 | 13.64% |
| 2018 | $-0.06 | 1.27% |
| 2017 | $-0.06 | 94.44% |
| 2016 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 11,103.32% |
US
|
|
| $4.09 | 16,870.95% |
IE
|
|
| $9.45 | 39,111.62% |
US
|
|
| $2.37 | 9,734.02% |
US
|
|
| $1.77 | 7,244.40% |
US
|
Questions about Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS)
What is Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS)?
Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.02, as of Jun 2026.
What was Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) was $0.04, compared with 0.00 in 2024.
How has Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($0.04) and lowest in 2020 ($-0.06).
How does Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Taiwan Biomaterial Co., Ltd.'s earnings per share (EPS) ($0.02) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.